| Year |
Citation |
Score |
| 2024 |
Seo DH, Lee SG, Choi SM, Kim HY, Park S, Jung SG, Jo YS, Lee J. Promoter mutation-independent TERT expression is related to immune-enriched milieu in papillary thyroid cancer. Endocrine-Related Cancer. PMID 39197475 DOI: 10.1530/ERC-24-0068 |
0.345 |
|
| 2023 |
Lee J, Jeong S, Lee HY, Park S, Jeong M, Jo YS. Comparative Analysis of Driver Mutations and Transcriptomes in Papillary Thyroid Cancer by Region of Residence in South Korea. Endocrinology and Metabolism (Seoul, Korea). PMID 37931624 DOI: 10.3803/EnM.2023.1758 |
0.324 |
|
| 2023 |
Ho J, Han M, Jung I, Jo YS, Lee J. Impact of thyroid hormone replacement on the risk of second cancer after thyroidectomy: a Korean National Cohort Study. Scientific Reports. 13: 16280. PMID 37770542 DOI: 10.1038/s41598-023-43461-8 |
0.324 |
|
| 2023 |
Ho J, Kim E, Lee M, Jung I, Jo YS, Lee J. Impact of thyroid cancer on the cancer risk in patients with non-alcoholic fatty liver disease or dyslipidemia. Scientific Reports. 13: 1076. PMID 36658156 DOI: 10.1038/s41598-023-28112-2 |
0.326 |
|
| 2022 |
Jeong S, Park S, Jo YS, Choi MJ, Lee G, Lee SG, Choi MC, Park H, Joo WD, Jung SG, Lee J. Long Non-Coding RNA-Based Functional Prediction Reveals Novel Targets in Notch-Upregulated Ovarian Cancer. Cancers. 14. PMID 35326706 DOI: 10.3390/cancers14061557 |
0.343 |
|
| 2021 |
Ho J, Kim E, Han M, Jung I, Lee J, Jo YS. ASO Author Reflection: The Effect of Dyslipidemia on the Occurrence of Secondary Cancer in Patients With thyroid Cancer. Annals of Surgical Oncology. PMID 33751299 DOI: 10.1245/s10434-021-09636-1 |
0.36 |
|
| 2021 |
Ho J, Kim E, Han M, Jung I, Lee J, Jo YS. Impact of Dyslipidemia on the Risk of Second Cancer in Thyroid Cancer Patients: A Korean National Cohort Study. Annals of Surgical Oncology. PMID 33483844 DOI: 10.1245/s10434-020-09570-8 |
0.358 |
|
| 2020 |
Yoon J, Lee E, Koo JS, Yoon JH, Nam KH, Lee J, Jo YS, Moon HJ, Park VY, Kwak JY. Artificial intelligence to predict the BRAFV600E mutation in patients with thyroid cancer. Plos One. 15: e0242806. PMID 33237975 DOI: 10.1371/journal.pone.0242806 |
0.347 |
|
| 2018 |
Lee WK, Lee SG, Yim SH, Kim D, Kim H, Jeong S, Jung SG, Jo YS, Lee J. Whole Exome Sequencing Identifies a Novel Hedgehog-Interacting Protein G516R Mutation in Locally Advanced Papillary Thyroid Cancer. International Journal of Molecular Sciences. 19. PMID 30241415 DOI: 10.3390/ijms19102867 |
0.374 |
|
| 2016 |
Jo YS, Oh HR, Kim MS, Yoo NJ, Lee SH. Frameshift mutations of OGDH, PPAT and PCCA genes in gastric and colorectal cancers. Neoplasma. 63. PMID 27468871 DOI: 10.4149/neo_2016_504 |
0.445 |
|
| 2016 |
Jo YS, Kim MS, Yoo NJ, Lee SH. Frameshift Mutation of MED25, a Transcription Regulator, and its Mutational Heterogeneity in Colorectal Cancers. Pathology Oncology Research : Por. PMID 27406034 DOI: 10.1007/s12253-016-0092-3 |
0.416 |
|
| 2016 |
Jo YS, Kim MS, Yoo NJ, Lee SH, Song SY. ADNP encoding a transcription factor interacting with BAF complexes exhibits frameshift mutations in gastric and colorectal cancers. Scandinavian Journal of Gastroenterology. 1-6. PMID 27308845 DOI: 10.1080/00365521.2016.1193220 |
0.361 |
|
| 2016 |
Jo YS, Kim MS, Yoo NJ, Lee SH. Somatic mutation of a candidate tumour suppressor MGA gene and its mutational heterogeneity in colorectal cancers. Pathology. PMID 27306572 DOI: 10.1016/j.pathol.2016.04.010 |
0.419 |
|
| 2016 |
Kim D, Lee WK, Jeong S, Seol MY, Kim H, Kim KS, Lee EJ, Lee J, Jo YS. Upregulation of long noncoding RNA LOC100507661 promotes tumor aggressiveness in thyroid cancer. Molecular and Cellular Endocrinology. PMID 27151833 DOI: 10.1016/j.mce.2016.05.002 |
0.488 |
|
| 2016 |
Jo YS, Choi MR, Song SY, Kim MS, Yoo NJ, Lee SH. Frameshift Mutations of HSPA4 and MED13 in Gastric and Colorectal Cancers. Pathology Oncology Research : Por. PMID 27129500 DOI: 10.1007/s12253-016-0070-9 |
0.504 |
|
| 2016 |
Jo YS, Kim MS, Yoo NJ, Lee SH. NSD1 encoding a histone methyltransferase exhibits frameshift mutations in colorectal cancers. Pathology. 48: 284-6. PMID 27020509 DOI: 10.1016/j.pathol.2016.01.002 |
0.495 |
|
| 2016 |
Jo YS, Kim MS, Yoo NJ, Lee SH. Frameshift Mutations of AKAP9 Gene in Gastric and Colorectal Cancers with High Microsatellite Instability. Pathology Oncology Research : Por. PMID 26786868 DOI: 10.1007/s12253-016-0042-0 |
0.434 |
|
| 2015 |
Jo YS, Kim MS, Yoo NJ, Lee SH. Inactivating frameshift mutation of PBRM1, a putative tumour suppressor gene, in colorectal cancers. Scandinavian Journal of Gastroenterology. 1-2. PMID 26634388 DOI: 10.3109/00365521.2015.1119305 |
0.443 |
|
| 2015 |
Jo YS, Kim MS, Lee JH, Lee SH, An CH, Yoo NJ. Frequent frameshift mutations in 2 mononucleotide repeats of RNF43 gene and its regional heterogeneity in gastric and colorectal cancers. Human Pathology. PMID 26297255 DOI: 10.1016/j.humpath.2015.07.004 |
0.398 |
|
| 2015 |
Jo YS, Kim MS, Lee SH, Yoo NJ. Mutational Heterogeneity of MED23 Gene in Colorectal Cancers. Pathology Oncology Research : Por. PMID 26152846 DOI: 10.1007/s12253-015-9959-y |
0.439 |
|
| 2013 |
Lee SE, Lee JU, Lee MH, Ryu MJ, Kim SJ, Kim YK, Choi MJ, Kim KS, Kim JM, Kim JW, Koh YW, Lim DS, Jo YS, Shong M. RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancer. Oncogenesis. 2: e55. PMID 23857250 DOI: 10.1038/oncsis.2013.12 |
0.414 |
|
| 2011 |
Lee SJ, Lee MH, Kim DW, Lee S, Huang S, Ryu MJ, Kim YK, Kim SJ, Kim SJ, Hwang JH, Oh S, Cho H, Kim JM, Lim DS, Jo YS, et al. Cross-regulation between oncogenic BRAF(V600E) kinase and the MST1 pathway in papillary thyroid carcinoma. Plos One. 6: e16180. PMID 21249150 DOI: 10.1371/journal.pone.0016180 |
0.305 |
|
| 2006 |
Jo YS, Li S, Song JH, Kwon KH, Lee JC, Rha SY, Lee HJ, Sul JY, Kweon GR, Ro HK, Kim JM, Shong M. Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer. The Journal of Clinical Endocrinology and Metabolism. 91: 3667-70. PMID 16772349 DOI: 10.1210/jc.2005-2836 |
0.385 |
|
| Show low-probability matches. |